Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Risperidone - Generic Drug Details

« Back to Dashboard

What are the generic sources for risperidone and what is the scope of patent protection?

Risperidone
is the generic ingredient in three branded drugs marketed by Ajanta Pharma Ltd, West-ward Pharms Int, Prinston Inc, Teva, Bio Pharm Inc, Sandoz, Zydus Pharms Usa, Apotex Inc, Dr Reddys Labs Ltd, Cadista Pharms, Sun Pharm Inds Inc, Mylan Pharms Inc, Jubilant Generics, Ani Pharms Inc, West Ward Pharms, Zydus Pharms Usa Inc, Sun Pharm Inds Ltd, Cipla, Wockhardt, Janssen Pharms, Taro, Lifestar Pharma, Vintage, Tris Pharma Inc, Watson Labs, Aurobindo Pharma, Pliva Hrvatska Doo, Oxford Pharms, Amneal Pharms, Ratiopharm, Silarx Pharms Inc, Synthon Pharms, Mylan, Torrent Pharms, Par Pharm, Actavis Labs Fl Inc, and Precision Dose, and is included in forty-eight NDAs. There are nine patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Risperidone has one hundred and thirty-two patent family members in thirty-four countries.

There are thirty drug master file entries for risperidone. Sixty suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: risperidone

Tradenames:3
Patents:9
Applicants:37
NDAs:48
Drug Master File Entries: see list30
Suppliers / Packagers: see list60
Bulk Api Vendors: see list82
Clinical Trials: see list106
Patent Applications: see list5,246
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:risperidone at DailyMed

Pharmacology for Ingredient: risperidone

Tentative approvals for RISPERIDONE

Applicant Application No. Form Dosage
► Subscribe► SubscribeSOLUTION; ORAL1MG/ML
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics
RISPERIDONE
risperidone
TABLET, ORALLY DISINTEGRATING;ORAL090839-005Nov 4, 2011ABRXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
RISPERIDONE
risperidone
TABLET, ORALLY DISINTEGRATING;ORAL076996-004Apr 19, 2011ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
RISPERIDONE
risperidone
TABLET;ORAL078036-001Mar 10, 2014ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
RISPERIDONE
risperidone
TABLET;ORAL076879-003Oct 24, 2008ABRXNoNo► Subscribe► Subscribe
West Ward Pharms
RISPERIDONE
risperidone
TABLET;ORAL078740-005May 29, 2009DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot